Kranus Health

Munich, Germany · Founded 2020 · Privately Held (backing)

Operator of a digital health platform intended to help patients lead a better life. Kranus Health is based in Munich, Germany and was founded in 2020. Its last reported valuation was $24.7 million in Jun 2022. It has raised $28 million.

Last reported valuation
$24.7M
Oct 2026
Priced at
—
Total raised
$28.0M
Last round
—

Kranus Health key facts

as of Oct 2026
  • Operator of a digital health platform intended to help patients lead a better life.
  • Kranus Health is valued at approximately $24.7M as of Oct 2026 (last reported valuation).
  • It has raised $28.0M; the latest was Later Stage VC in Nov 2025.
  • Notable investors include High-Tech Gründerfonds, Superangels, A-Round Capital, BaseCamp Ventures, CapHorn Invest — 15 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$24.7M

Kranus Health's last reported valuation, Jun 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Kranus Health with a free account
  • ·The complete investor list: 15 names
  • ·Watch Kranus Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kranus Health funding rounds

No rounds on record

No funding rounds for Kranus Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Kranus Health valuation

Kranus Health's last reported valuation was $24.7 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

Kranus Health investors

15 investors are on record for Kranus Health, including High-Tech Gründerfonds, Superangels, A-Round Capital and BaseCamp Ventures.

About Kranus Health

Operator of a digital health platform intended to help patients lead a better life. The company's platform addresses a broad range of urological conditions, including women's health (incontinence), andrology (erectile dysfunction), and prostate enlargement (BPH) by integrating with both doctors and patients throughout the treatment journey, offering personalized treatments, enabling patients to enhance the quality of life and ensure better health outcomes, backed by clinical (randomized controlled trial) RCT trials with demonstrated proven efficacy in improving patient outcomes.

Sector
Healthcare
HQ
Munich, Germany
Founded
2020
Employees
66
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.